The deal involves Eli Lilly, which makes Zepbound and Mounjaro, and Novo Nordisk, the maker of Ozempic and Wegovy. The drugs, known as GLP-1 medications, now cost as much as $1,350 a month. Under the ...
Kansas turned in a 60-page application last week in hopes of receiving a share of $50 billion in federal money designed to ...
North Carolina already reduced Medicaid reimbursement rates. Now hard-hit rural hospitals are now bracing for federal cuts.
More than half a million Ohioans rely on subsidies to get health insurance through the Affordable Care Act, and tax credits ...
Millions of Americans rely on public assistance programs such as the Supplemental Nutrition Assistance Program (SNAP) and ...
Secretary Mitch Roob announced recommendations from the Applied Behavior Analysis (ABA) Working Group to address ...
Among applications and summaries publicly shared by states, themes include workforce development, telehealth, and access to healthy food.
About 20 recommendations, released Wednesday by a state-backed panel, could shape upcoming service changes for thousands of ...
Planned Parenthood reports the legislation cost $45 million in September alone, forcing clinics to cover Medicaid patient ...
Democrats are turning down federal dollars that could transform the lives of students — because the program originated under Donald Trump.
The Trump administration’s recent deal with drug manufacturers to lower the cost of popular GLP-1 weight-loss medications is ...
Parents of 22 children who have been diagnosed with autism spectrum disorder said cutting reimbursement rates for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback